玻尿酸的全球市場 - 市場規模，佔有率，成長分析，各用途 - 產業預測(2023年～2030年)

Global Hyaluronic Acid Market Size, Share, Growth Analysis, By Application(Dermal Fillers, Osteoarthritis) - Industry Forecast 2023-2030

出版日期: 2023年07月20日 | 出版商:

SkyQuest | 英文 165 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球玻尿酸的市場規模將從2022年的94億美元到2030年達到168億美元，在預測期間(2023年～2030年)時將以年複合成長率7.58％的速度成長。

在化妝品和醫療保健行業需求不斷增長的推動下，全球透明質酸市場正在穩步增長。透明質酸是一種存在於人體內的天然物質，廣泛用於護膚品、真皮填充劑和關節治療。人們越來越認識到透明質酸在維持皮膚健康和減少衰老跡象方面的好處，這推動了市場的擴張。技術進步和研發活動進一步促進了市場的增長潛力。

促進因素

整形外科醫生和美容診所的激增促使進行美容手術的數量增加。對肉毒桿菌和透明質酸注射劑等非手術美容手術的需求不斷增長，正在推動透明質酸行業的發展。

阻礙因素

然而，由於競爭加劇以及神經?胺和維生素C 等其他護膚化合物的日益普及，透明質酸市場面臨挑戰。此外，嚴格的法規，特別是有關皮膚和護髮產品的法規，可能會在可預見的未來阻礙市場的增長

趨勢

透明質酸市場將受益於兩個普遍趨勢：老年人口的增加和肥胖患病率的上升。

本報告提供全球玻尿酸市場相關調查分析，提供市場動態及預測，市場區隔分析，企業簡介等資訊。

Allergan plc
Anika Therapeutics, Inc.
Ferring Pharmaceuticals
Galderma S.A.
Genzyme Corporation
Hyaltech Ltd.
LG Life Sciences Ltd.
Medytox, Inc.
Merz Pharma GmbH & Co. KGaA
Salix Pharmaceuticals, Inc.
Sanofi S.A.
Seikagaku Corporation
Shanghai Jingfeng Pharmaceutical Co., Ltd.
Shiseido Company, Limited
Sinclair Pharma plc
Smith & Nephew plc
Teva Pharmaceutical Industries Ltd.
Valeant Pharmaceuticals International, Inc.
Zimmer Biomet Holdings, Inc.
AstraZeneca

簡介目錄

Product Code: SQSG15E2026

Hyaluronic Acid Market size was valued at USD 8.74 billion in 2021 and is poised to grow from USD 9.4 billion in 2022 to USD 16.8 billion by 2030, growing at a CAGR of 7.58% in the forecast period (2023-2030).

The global hyaluronic acid market is experiencing steady growth, driven by increasing demand from the cosmetic and healthcare sectors. Hyaluronic acid, a natural substance found in the human body, is widely used in skincare products, dermal fillers, and joint treatments. The rising awareness about the benefits of hyaluronic acid in maintaining skin health and reducing signs of aging is fueling market expansion. Technological advancements and research and development activities are further contributing to the market's growth potential.

Top-down and bottom-up approaches were used to estimate and validate the size of Hyaluronic Acid and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Segments covered in this report:

Hyaluronic Acid Marketis segmented on the basis of application and region. Based on application, the Hyaluronic Acid Market is segmented into Dermal Fillers, Osteoarthritis, Ophthalmic, and Vesicoureteral Reflux. Based on region, the global Hyaluronic acid market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Driver

The proliferation of plastic surgeons and cosmetic clinics has led to an increase in the number of aesthetic operations being performed. The growing demand for nonsurgical cosmetic procedures, such as Botox and hyaluronic acid injectables, is driving the hyaluronic acid industry.

Restrain

However, the hyaluronic acid market faces challenges due to rising competition and the growing popularity of other skincare compounds like ceramides and vitamin C. Additionally, strict regulations, particularly regarding skin and hair care products, could hinder the market's growth in the foreseeable future

Trend

The hyaluronic acid market stands to benefit from two prevailing trends: the increasing elderly population and the rising prevalence of obesity. Dermal fillers, particularly those made from hyaluronic acid, are the most commonly used nonsurgical injectable procedures for addressing facial soft tissue abnormalities, as reported by the American Society of Plastic Surgeons (ASAPS). These fillers are utilized to smoothen wrinkles and creases, treat under-eye dark circles, minimize scars, and rejuvenate the skin. These advancements are expected to drive the expansion of the hyaluronic acid market and sustain its growth throughout the projected period.

Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
Drivers
Opportunities
Restraints
Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
Drivers
Opportunities
Restraints
Challenges
- Regulatory Landscape
- Porters Analysis
Competitive rivalry
Threat of Substitute Products
Bargaining Power of Buyers
Threat of New Entrants
Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
Political Impact
Economic Impact
Social Impact
Technical Impact
Environmental Impact
Legal Impact
Global Hyaluronic Acid Market by Application
- Market Overview
- Dermal Fillers
- Osteoarthritis
- Ophthalmic
- Vesicoureteral Reflux
Global Hyaluronic Acid Market Size by Region
- Market Overview
- North America
USA
Canada
- Europe
Germany
Spain
France
UK
Rest of Europe
- Asia Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
- Latin America
Brazil
Rest of Latin America
- Middle East & Africa (MEA)
GCC Countries
South Africa
Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
By Development
By Company
By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- Allergan plc
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Anika Therapeutics, Inc.
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Ferring Pharmaceuticals
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Galderma S.A.
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Genzyme Corporation
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Hyaltech Ltd.
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- LG Life Sciences Ltd.
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Medytox, Inc.
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Merz Pharma GmbH & Co. KGaA
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Salix Pharmaceuticals, Inc.
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Sanofi S.A.
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Seikagaku Corporation
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Shanghai Jingfeng Pharmaceutical Co., Ltd.
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Shiseido Company, Limited
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Sinclair Pharma plc
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Smith & Nephew plc
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Teva Pharmaceutical Industries Ltd.
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Valeant Pharmaceuticals International, Inc.
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Zimmer Biomet Holdings, Inc.
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- AstraZeneca
Company Overview
Business Segment Overview
Financial Updates
Key Developments